Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.OtgQHJex.js ...

Primary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin's lymphoma (NHL) confined to the nervous system. The disease is managed quite differently from other primary brain ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

Follicular lymphoma is the second most common form of non-Hodgkin lymphoma (NHL), and ... and it has a five-year survival rate of only 20% for patients in the third line and later.

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the CD19-directed CAR T cell therapy, which is already approved in the EU for certain lymphomas, be authorised to treat ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

A RECENT study highlights the benefits of using immune checkpoint inhibitors (ICIs) before allogeneic blood or marrow transplantation (alloBMT) for patients with relapsed classic Hodgkin lymphoma (cHL ...

Trusted resource of information on Cancer that includes articles, news, videos, animations, quizzes, calculators and drugs.

If you’re taking certain medication, your dermatologist will also check for skin diseases like skin cancer, vitiligo, and non-cancerous skin growths ... “Primary cutaneous T-cell lymphoma (mycosis ...

Spinal cord compression can also occur through direct tumor extension, which is frequently seen in non-Hodgkin's lymphoma ... cord is not relieved quickly. Prognosis depends greatly on the ...